Time to reconsider saline as the ideal rinsing solution during abdominal surgery

American Journal of Surgery

Volumn 192, Issue 3, 2006, Pages 281-285

  Polubinska A ^a   Winckiewicz, M ^a   Staniszewski, R ^a   Breborowicz A ^a   Oreopoulos, D G ^b  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Dialysis fluid; Fibrinolytic activity; Mesothelium; Peritoneal adhesions

Indexed keywords

EARLE SOLUTION; GLUCOSE DEGRADATION PRODUCT; HANKS SOLUTION; INTERLEUKIN 6; LACTATE DEHYDROGENASE; PERITONEAL DIALYSIS FLUID; PLASMINOGEN ACTIVATOR INHIBITOR; SODIUM CHLORIDE; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG;

ABDOMINAL SURGERY; ARTICLE; CELL ADHESION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; CYTOSOL; FIBRINOLYSIS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MESOTHELIUM CELL; MONOLAYER CULTURE; PRIORITY JOURNAL;

CELL CULTURE TECHNIQUES; CELL SURVIVAL; DIALYSIS SOLUTIONS; EPITHELIAL CELLS; FIBRINOLYSIS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INTERLEUKIN-6; ISOTONIC SOLUTIONS; OSMOLAR CONCENTRATION; PERITONEAL CAVITY; SODIUM CHLORIDE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 33747120928     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2005.05.047     Document Type: Article

References (24)

1. Jack D. Sticky situation. surgical adhesions and adhesives. Lancet 351 (1998) 118
2. Dobbie J., Anderson J., and Hind C. Long-term effects of peritoneal dialysis on peritoneal morphology. Perit Dial Int 14 suppl 3 (1994) S16-S20
3. Kawaguchi Y., Kawanishi H., Mujais S., et al. Encapsulating peritoneal sclerosis. definition, etiology, diagnosis and treatment. Perit Dial Int 20 suppl 4 (2000) S43-S55
4. Mutsaers S.E. The mesothelial cell. Int J Biochem Cell Biol 36 (2004) 9-16
5. Holmdahl L. The role of fibrinolysis in adhesion formation. Eur J Surg 557 suppl (1997) 24-31
6. Holmdahl L., Eriksson E., and Al-Jabreen M. Fibrinolysis in human peritoneum during operation. Surgery 119 (1996) 701-705
7. Hellebrekers B.W., Trimbos-Kemper G.C., Bakkum E.A., et al. Short-term effect of surgical trauma on rat peritoneal fibrinolytic activity and its role in adhesion formation. Thromb Haemost 84 (2000) 876-881
8. Sitter T., Spannagl M., Schiffl H., et al. Modulation of procoagulant and fibrinolytic system components of mesothelial cells by inflammatory mediators. Am J Physiol 271 (1996) R1256-R1263
9. Falk P., Ma C., Chegini N., and Holmdahl L. Differential regulation of mesothelial cell fibrinolysis bt transforming growth factor beta 1. Scand J Clin Lab Invest 60 (2000) 439-448
10. Ince A., Eroglu A., Tarhan O., and Bulbul M. Peritoneal fibrinolytic activity in peritonitis. Am J Surg 183 (2002) 67-69
11. Sitter T., Spannagl M., Schiffl M., et al. Imbalance between intraperitoneal coagulation and fibrinolysis during peritonitis of CAPD patients. the role of mesothelial cells. Nephrol Dial Transplant 10 (1995) 677-683
12. Dobbie J.W., and Jasani M.K. Role of imbalance of intracavity fibrin formation and removal in the pathogenesis of peritoneal lesions in CAPD. Perit Dial Int 17 (1997) 121-124
13. Vardhan A., Zweers M.M., Gokal R., and Krediet R.T. A solutions portfolio approach in peritoneal dialysis. Kidney Int 64 suppl 88 (2003) S114-S123
14. Breborowicz A., Rodela H., and Oreopoulos D.G. Toxicity of osmotic solutes on human mesothelial cells in vitro. Kidney Int 41 (1992) 1280-1285
15. van Westreenen M., van den Tol P.M., Pronk A., et al. Perioperative lavage promotes intraperitoneal adhesion in the rat. Eur Surg Res 31 (1999) 196-201
16. Shao J.C., Yorioka N., Nishida Y., and Yamakido M. Effect of pH and glucose on cultured human peritoneal mesothelial cells. Scand J Urol Nephrol 33 (1999) 248-256
17. Wang T., Heimburger O., Qureshi A.R., et al. Physiological saline is not a biocompatible peritoneal dialysis solution. Int J Artif Organs 22 (1999) 88-93
18. Nakayama M. Treatment strategies for the management of EPS-steroids and peritoneal lavage [in Japanese]. Fukumakutoseki (2004) 83-87
19. Honma S. Clinical experiences of using peritoneal lavage after withdrawing from CAPD. Fukumakutoseki (2002) 342-344
20. Styszyński A., Podkowka R., Wieczorowska-Tobis K., et al. Glucose suppresses peritoneal inflammatory reactions and mesothelial hyperplasia caused by intraperitoneal saline infusion. Adv Perit Dial 18 (2002) 21-25
21. Witowski J., Korybalska K., Wisniewska J., et al. Effect of glucose degradation products on human peritoneal mesothelial cell function. J Am Soc Nephrol 11 (2000) 729-739
22. Morgan L.W., Wieslander A., Davies M., et al. Glucose degradation products (GDP) retard remesotheliazation independently of D-glucose concentration. Kidney Int 64 (2003) 1854-1866
23. Wieczorowska-Tobis K., Styszyński A., Połubinska A., et al. Hypertonicity of dialysis fluid suppresses intraperitoneal inflammation. Adv Perit Dialy 16 (2000) 262-266
24. Wieczorowska-Tobis K., Połubinska A., Breborowicz A., and Oreopoulos D.G. A comparison of the biocompatibility of phosphate-buffered saline and Dianeal 3.86% in the rat model of peritoneal dialysis. Adv Perit Dial 17 (2001) 42-46